On the other hand, we and others have reported that NFATc2 expression in carcinomas contributes to tumor growth and TIC phenotypes.[22, 24, 25] These findings led us to hypothesize that galectin‐9 could play dual roles in tumor propagation and modulation of the immune microenvironment. Here, NFATC2 is linked to carcinoma.